Latest Status epilepticus Stories
RnRMarketResearch.com adds "Status Epilepticus - Pipeline Review, H2 2014" to its store. This report provides an overview of the Status Epilepticus's therapeutic pipeline. DALLAS, Jan.
SALT LAKE CITY and TORONTO, June 25, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development
A newly discovered biomarker – visible in brain scans for hours after febrile seizures – predicts which individuals will subsequently develop epilepsy.
SALT LAKE CITY and TORONTO, June 17, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development
USL261 Demonstrates Promising PK, PD and Safety Profiles in Patients with Epilepsy PHILADELPHIA, April 29, 2014 /PRNewswire/ -- Upsher-Smith
Although some studies have suggested that the drug lorazepam may be more effective or safer than the drug diazepam in treating a type of epileptic seizures among children, a randomized trial finds that lorazepam is not better at stopping seizures compared to diazepam.
- A volcanic mudflow.